bioRxivCancer BiologyPreprint
Uncovering cancer dependencies in peptide-interacting protein pockets
Mihkel ÖrdiD, Liz KoganiD, Devin A. Bradburn, Michelle Leiser, Mardo KõivomägiiD, Norman E. DaveyiD, Pau CreixelliD
Abstract
Cancer cells often become dependent on specific molecular functions. As many proteins perform multiple functions mediated by different pockets and interfaces, we hypothesized that we could identify distinct cancer dependencies and therapeutic vulnerabilities by disrupting peptide-binding pockets. To test this hypothesis, we screened a proteome-wide library of 7152 genetically encoded peptides across nine cancer cell lines. We identify common and selective dependencies on peptide-binding pockets and find that gene knockout and peptide-mediated inhibition of pockets often drive divergent phenotypes. For the common-essential gene HCF1, we identify a therapeutic window by using inhibitory peptides with varying affinity. Moreover, peptides targeting TLE1-4 reveal a dependency hidden in genetic screens by homolog redundancy. We also uncover that peptides inhibiting cyclin D drive specific suppression of leukemia cell proliferation and demonstrate that these peptides improve the potency of CDK4/6 inhibitors. Overall, our screening platform facilitates data-driven prioritization of molecular pockets for subsequent therapeutic translation.
- organism: human
- assay: proteomics
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells
S. Fischer, V. T. Trinh, … O. Vazquez·bioRxiv·Nov 4, 2022
- Inferring tumor-specific cancer dependencies through integrating ex-vivo drug response assays and drug-protein profiling
Alina Batzilla, Junyan Lu, … Wolfgang K. Huber·PLoS Computational BiologyPeer-reviewed·Aug 22, 2022
- A blueprint for mutation-defined hallmark vulnerabilities across human cancers
Ran Xu, Rebecca San Gil, … Yuchen Feng·bioRxiv·Oct 24, 2025
- The landscape of metabolic pathway dependencies in cancer cell lines
J. H. Joly, B. T. Chew, N. A. Graham·bioRxiv·Oct 5, 2020
- Palmitoylation is critically required for cancer intrinsic PD-1 expression and functions
- Cancer type-specific prioritization strategy for targetable dependencies developed from the DepMap profile of head and neck cancer
A. C. Cao, M. K. Sannigrahi, … D. Basu·bioRxiv·Jun 12, 2022